Summary from the original article
Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US Food and Drug Administration (FDA) has said.
AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.
Upgrade this serverCompanies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US Food and Drug Administration (FDA) has said.
2 days ago · news.sky.com · You are reading this one
CNBC · 2 days ago
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepboundthenationalherald.com · 2 days ago
FDA Adds Rare Vision-Loss Warning to Popular GLP-1 DrugsNBC News · 2 days ago
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
